4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-22-003993
Options or other derivatives
- CHIEF COMMERCIAL OFFICER acquired 69,368 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2022-04-07 | Grant or award · Share Option | +59,460 | 59,460 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2022-04-07 | Grant or award · Restricted Share Unit | +9,908 | 9,908 | D | ||
Loading xslF345X03/form4-04112022_040417.xml…